Lisinopril
Product Images NDC 70934-061

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 70934-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 061 30 Master Bottle Label Approval Rev B 07 19

70934 061 30 Master Bottle Label Approval Rev B 07 19
Lisinopril Tablets USP 20 mg label for a 30-tablet package by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label includes dosage strength, package size, storage instructions, and prescription-only status, along with NDC 70934-061-30 and manufacturing details.*
FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)
Chemical structure of lisinopril dihydrate, showing its molecular components including amino acid and carboxyl groups with two molecules of water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.